WallStreetZenWallStreetZen

NASDAQ: VYNE
Vyne Therapeutics Inc Stock Ownership - Who owns Vyne Therapeutics?

OverviewForecastEarningsRevenueDividendOwnership

Insider buying vs selling

Have Vyne Therapeutics Inc insiders been buying or selling?

Buy
Sell
NameRoleDateSharesPriceValue
David DomzalskiPRESIDENT AND CEO2026-05-2930,791$0.31
$9.55kBuy
Tyler ZerondaCHIEF FINANCIAL OFFICER2026-03-314,007$0.60
$2.40kSell
David DomzalskiPRESIDENT AND CEO2026-03-3114,232$0.60
$8.51kSell
Mutya HarschCHIEF LEGAL OFFICER AND GC2026-03-314,007$0.60
$2.40kSell
Iain StuartCHIEF SCIENTIFIC OFFICER2026-03-312,876$0.60
$1.72kSell
David DomzalskiPRESIDENT AND CEO2025-12-3112,684$0.58
$7.36kSell
Mutya HarschCHIEF LEGAL OFFICER AND GC2025-12-313,579$0.58
$2.08kSell
Iain StuartCHIEF SCIENTIFIC OFFICER2025-12-312,448$0.58
$1.42kSell
Tyler ZerondaCHIEF FINANCIAL OFFICER2025-12-317,858$0.58
$4.56kSell
David DomzalskiPRESIDENT AND CEO2025-09-3012,676$0.34
$4.25kSell

1 of 2

VYNE insiders have sold more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership

Be the first to know when VYNE insiders and whales buy or sell their stock.

VYNE Shareholders

What type of owners hold Vyne Therapeutics Inc stock?

Institutional
Insider
Retail
NameHoldSharesValueType
Perceptive Advisors LLC14.80%4,935,057$3.12MInsider
Albert Cha12.03%4,011,236$2.54MInsider
Vivo Capital VIII LLC12.03%4,011,236$2.54MInsider
Remeditex Ventures LLC8.28%2,761,663$1.75MInsider
Presidio Partners 2007 GP LP7.82%2,608,540$1.65MInsider
Anson Funds Management LP7.45%2,486,212$1.57MInstitution
Nantahala Capital Management LLC6.00%2,000,000$1.27MInstitution
Lynx1 Capital Management LP4.88%1,628,700$1.03MInstitution
Shay Capital LLC4.83%1,610,242$1.02MInstitution
Venbio Global Strategic Fund II LP4.38%1,461,552$925.16kInsider

1 of 3

VYNE vs Biotech Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
VYNE35.69%64.31%Net SellingNet Buying
RKTO4.11%42.24%Net Selling
PLRZ2.23%5.29%Net SellingNet Selling
ALLR5.97%16.02%Net Selling
PTN3.98%96.02%Net Selling
View Top Biotech Stocks

Vyne Therapeutics Stock Ownership FAQ

Who owns Vyne Therapeutics?

Vyne Therapeutics (NASDAQ: VYNE) is owned by 43.34% institutional shareholders, 78.09% Vyne Therapeutics insiders, and 0.00% retail investors. Perceptive Advisors LLC is the largest individual Vyne Therapeutics shareholder, owning 4.94M shares representing 14.80% of the company. Perceptive Advisors LLC's Vyne Therapeutics shares are currently valued at $3.11M.

If you're new to stock investing, here's how to buy Vyne Therapeutics stock.
©2026 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.